AMI Research Initiates Analyst Coverage on Pressure BioSciences, Inc.; BUY
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 02/29/12 -- AMI Research (), a leading provider of equity research reports and a subsidiary of IR Firm, Hawk Associates Inc., announced today that it has initiated equity research coverage on Pressure BioSciences, Inc. (NASDAQ: PBIO).
AMI president Peter J. D'Agostino said, "A highlight to Pressure BioSciences' story is its aggressive commercialization effort that management has begun early this year. This, along with Pressure BioSciences' string of new product offerings, will pave the way to the company's profitability. We expect impressive top-line growth in the upcoming quarters, which eventually will be reflected by the company's EPS."
AMI Research provides an institutional-quality, equity research initiation report detailing Pressure BioSciences' key statistics, management, growth catalysts, financial outlook and valuation. The complete 8-page report is available to download for free at the AMI Research website,
Headquartered in South Easton, MA, Pressure BioSciences was founded in 2004. Pressure BioSciences, Inc. (NASDAQ: PBIO) is a life science, medical device company that developments and commercializes pressure cycling technology (PCT). PCT technology uses instrumentation that cycles pressure between ambient and ultra-high levels at controlled temperatures to control the interactions of bio-molecules. PBIO's technology is used genomic, proteomic, and small molecule sample preparation as well. For additional information about Pressure BioSciences Inc., visit .
AMI Research provides fundamental business analysis for promising companies that do not have traditional Wall Street analyst coverage. AMI Research creates comprehensive and quality equity research reports for small cap and microcap companies that need to reach investors. These detailed reports provide retail, individual and institutional investors with an in-depth understanding of a company's intrinsic value and its technology. The AMI equity research reports detail the company's industry, strategic position, core business model, financial history and future growth catalysts. Please visit .
For more information, contact:
Peter J. D'Agostino
President
212.541.2465
405 Lexington Avenue
Chrysler Building, 26th Floor
New York, NY 10174
Tel. 212.541.2465
E-mail:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.02.2012 - 10:00 Uhr
Sprache: Deutsch
News-ID 1088306
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 174 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"AMI Research Initiates Analyst Coverage on Pressure BioSciences, Inc.; BUY
"
steht unter der journalistisch-redaktionellen Verantwortung von
AMI Research (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
